Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when NGNE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsNeurogene stockholders approve directors, executive pay at 2026 Annual Meeting
Filed June 4, 2026 · Period ending June 3, 2026 · ~1 min read
Key Changes
-
low
Stockholders elected Robert Baffi and Rohan Palekar as Class III directors for three-year terms through 2029, with both receiving strong support (94% and 99% approval respectively).
Item 5.07 verify on EDGAR → -
low
Executive compensation approved on advisory basis with 99% support, indicating shareholder satisfaction with management pay practices.
Item 5.07 verify on EDGAR → -
low
Deloitte & Touche LLP ratified as 2026 auditor, though 17% of votes cast were against the appointment—a notable minority dissent for an auditor vote.
Item 5.07 verify on EDGAR → -
low
Stockholders voted for annual say-on-pay votes going forward, with company committing to yearly advisory votes on executive compensation.
Item 5.07 verify on EDGAR →
Summary
Neurogene held its 2026 Annual Meeting on June 3, with stockholders voting on standard governance matters. The meeting produced no surprises: directors were re-elected with strong margins, executive compensation received overwhelming approval, and shareholders expressed preference for annual say-on-pay votes. The only item worth noting is that roughly 17% of votes cast opposed ratifying Deloitte & Touche as the company's auditor—higher than typical for auditor votes, though not enough to block the appointment.
For retail investors, this filing is purely procedural with no material business impact. The voting results suggest general shareholder satisfaction with board composition and executive pay. Watch for the company's proxy statement next year to see if management addresses the auditor dissent or if it was simply routine opposition from governance-focused funds.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Neurogene held its 2026 Annual Meeting on June 3, 2026, with stockholders approving director elections, executive compensation, and auditor ratification.
Show 4 minor / wording changes
Added in current filing · verify on EDGAR →
Election of two Class III directors, Robert Baffi and Rohan Palekar, each to serve until the 2029 annual meeting of stockholders and until their respective successors are elected and qualified
Stockholders elected Robert Baffi and Rohan Palekar as Class III directors to serve three-year terms until 2029. Baffi received 9,540,734 votes for and 548,736 withheld; Palekar received 10,058,331 votes for and 31,139 withheld. Both directors were elected with strong shareholder support.
Added in current filing · verify on EDGAR →
Approval on an advisory (non-binding) basis of the compensation of the Company’s named executive officers
Stockholders approved executive compensation on an advisory basis with 9,991,445 votes for, 36,394 against, and 61,631 abstaining. This non-binding say-on-pay vote indicates strong shareholder support for the company's executive compensation practices.
Added in current filing · verify on EDGAR →
Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026
Stockholders ratified Deloitte & Touche LLP as the independent auditor for 2026 with 9,345,925 votes for, 1,939,039 against, and 102,443 abstaining. The significant number of votes against (approximately 17% of votes cast) is notable but the appointment was still approved.
Added in current filing · verify on EDGAR →
In light of these voting results, the Company plans to hold future advisory votes on executive compensation annually until the next required vote on the frequency of such advisory votes, or until the Board of Directors of the Company otherwise determines that a different frequency is in the best interests of the Company and its stockholders.
Stockholders voted on the frequency of future say-on-pay votes, with 10,006,265 voting for annual votes, 3,407 for biennial, and 16,721 for triennial. The company will conduct annual advisory votes on executive compensation going forward based on this strong preference.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify